Progentec Diagnostics Unveils Groundbreaking Lupus Risk Assessment Tool Supported by OCAST Grant Progentec Diagnostics has developed a new immune index that can identify individuals at risk of lupus before clinical symptoms arise. Funded by OCAST, this research promises better patient outcomes.

Progentec Diagnostics Unveils Groundbreaking Lupus Risk Assessment Tool Supported by OCAST Grant #United_States #Oklahoma_City #Progentec #Lupus_Testing #OCAST_Grant